Jean Gudas

ImaginAb (United States)

Papers

1

Total Citations

18

H-Index

1

About

Jean Gudas is a pioneering translational researcher whose work bridges molecular imaging and surgical oncology, with a primary focus on prostate cancer. Her key research areas include the development of targeted molecular probes for intraoperative fluorescence guidance, particularly using prostate-specific membrane antigen (PSMA) as a biomarker. Gudas’s major contribution is the first-in-human study of the PSMA Minibody IR800-IAB2M, a novel humanised antibody fragment conjugated to a near-infrared fluorophore, designed to enable real-time visualisation of cancerous tissue during radical prostatectomy. This groundbreaking work, published in 2024 and already accumulating 18 citations, demonstrates her ability to translate complex molecular targeting into practical surgical tools that could reduce positive surgical margins and improve patient outcomes. By integrating preclinical development with clinical application, Gudas has positioned herself at the forefront of image-guided surgery, offering surgeons unprecedented molecular precision. Her achievements highlight the potential of theranostic approaches in urologic oncology, and her ongoing research continues to shape how fluorescence-guided surgery is implemented in the operating room, making her a key figure in the evolution of personalised cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy
18 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: ImaginAb (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago